| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5878299 | The American Journal of Medicine | 2014 | 25 Pages |
Abstract
Both inhaled budesonide (200 μg, bid) and oral dexamethasone (4 mg, bid) were effective for the prevention of acute mountain sickness, especially its severe form, compared with placebo. Budesonide caused fewer adverse reactions than dexamethasone.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Cheng-Rong MD, Guo-Zhu PhD, Jie PhD, Jun PhD, Pan MM, Shi-Zhu MD, Bai-Da MM, Xu-Gang PhD, Yong-Tao MM, Xiao MM, Jie MM, Lan MD, PhD,